IP Library Granted Patent US 7,888,125
Granted Patent B2
US 7,888,125 · App. 11/388,824 · Granted Feb 15, 2011

Calibration of fluidic devices

Assignee: Theranos, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,888,125
App. No.
11/388,824
Granted
Feb 15, 2011
Kind
B2
Abstract

The present invention provides methods of calibrating a fluidic device useful for detecting an analyte of interest in a bodily fluid. The invention also provides methods for assessing the reliability of an assay for an analyte in a bodily fluid with the use of a fluidic device. Another aspect of the invention is a method for performing a trend analysis on the concentration of an analyte in a subject using a fluidic device.

Claims (10)

1. A method of improving the accuracy of calibrating a fluidic system, comprising:

a) providing a system for detecting an analyte in a bodily fluid from a subject comprising a fluidic device for providing said bodily fluid, said fluidic device having a calibration assembly and a reader assembly for detecting the presence of said analyte;

b) measuring one or more parameters that are fitted to a calibration curve associated with said fluidic device;

c) comparing said one or more parameters with predetermined parameters associated with said fluidic device;

d) adjusting a signal output from the fluidic device by multiplying a ratio of said predetermined parameters to said one or more parameters, wherein the ratio is selected from the group consisting of: a ratio of maximum signal level during factory calibration to maximum signal level measured within the assay, and a ratio of minimun signal level during factory calibration to minimum signal level measured within an assay.

2. The method of claim 1 , wherein subsequent to said measuring, said one or more parameters are used to calculate an assay signal as a function of an analyte concentration.

3. The method of claim 1 , wherein subsequent to said measuring, said one or more parameters are used to calculate an analyte concentration as a function of an assay signal.

4. The method of claim 1 wherein said one or more parameters is selected from the group consisting of: a maximum signal, a maximum signal, a minimum signal level half way between the maximum signal and the minimum signal, and a shape parameter.

5. The method of claim 1 wherein said predetermined parameters are parameters determined at the time the fluidic device is manufactured.

6. The method of claim 5 wherein said calibration curve is used to scale a signal that is indicative of said analyte concentration.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2023
From: LABRADOR DIAGNOSTICS LLC
To: GOLDEN DIAGNOSTICS TOP CORP.
Reel/Frame 064262/0539 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2023
From: GOLDEN DIAGNOSTICS TOP CORP.
To: GOLDEN DIAGNOSTICS CORP.
Reel/Frame 064264/0393 →
CHANGE OF NAME Recorded Apr 7, 2020
From: THERANOS IP COMPANY LLC
To: LABRADOR DIAGNOSTICS LLC
Reel/Frame 052329/0716 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2018
From: THERANOS, INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 045101/0315 →
SECURITY INTEREST Recorded Dec 12, 2017
From: THERANOS IP COMPANY, LLC
To: FORTRESS CREDIT CORP.
Reel/Frame 044839/0568 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2017
From: THERANOS INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 044838/0909 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2006
From: GIBBONS, IAN; WANG, CHENGWANG; ROY, SHAUNAK; HOLMES, ELIZABETH A.
To: THERANOS, INC.
Reel/Frame 017997/0854 →
Continuity (5)
Provisional Application 60678801 · May 9, 2005
Provisional Application 60705489 · Aug 5, 2005
Provisional Application 60717192 · Sep 16, 2005
Provisional Application 60721097 · Sep 28, 2005
Related Publication 20060264781A1 · Nov 23, 2006